Peroxitech Therapeutics

Philadelphia, United States

Peroxitech Therapeutics operates as a biopharmaceutical company.

$25.0M raised

Dec 2022

Series A

Biopharma Biotechnology Health Care Life Science Medical

Top Investors

Xontogeny

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Peroxitech Therapeutics

How much funding has Peroxitech Therapeutics raised?

Peroxitech Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.

Who are Peroxitech Therapeutics's investors?

Peroxitech Therapeutics's investors include Xontogeny.

Where is Peroxitech Therapeutics headquartered?

Peroxitech Therapeutics is headquartered in Philadelphia, United States.

What does Peroxitech Therapeutics do?

Peroxitech Therapeutics operates as a biopharmaceutical company.

What stage is Peroxitech Therapeutics at?

Peroxitech Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 13, 2022.

MLA

"Peroxitech Therapeutics — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/peroxitech-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Peroxitech Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/peroxitech-therapeutics

Wikipedia (cite web)

{{cite web |title=Peroxitech Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/peroxitech-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 13, 2022.